
AbstractBackgroundCoronary heart disease (CHD) risk inversely associates with levels of high‐density lipoprotein cholesterol (HDL‐C). The protective effect of HDL is thought to depend on its functionality, such as its ability to induce cholesterol efflux.Materials and methodsWe compared plasma cholesterol efflux capacity between male familial hypercholesterolaemia (FH) patients with and without CHD relative to their non‐FH brothers, and examined HDL constituents including sphingosine‐1‐phosphate (S1P) and its carrier apolipoprotein M (apoM).ResultsSeven FH patients were asymptomatic and six had experienced a cardiac event at a mean age of 39 years. Compared to their non‐FH brothers, cholesterol efflux from macrophages to plasma from the FH patients without CHD was 16 ± 22% (mean ± SD) higher and to plasma from the FH patients with CHD was 7 ± 8% lower (P = 0·03, CHD vs. non‐CHD). Compared to their non‐FH brothers, FH patients without CHD displayed significantly higher levels of HDL‐cholesterol, HDL‐S1P and apoM, while FH patients with CHD displayed lower levels than their non‐FH brothers.ConclusionsA higher plasma cholesterol efflux capacity and higher S1P and apoM content of HDL in asymptomatic FH patients may play a role in their apparent protection from premature CHD.
Adult, Male, Heterozygote, Coronary Disease, Apolipoproteins M, high-density lipoprotein, Hyperlipoproteinemia Type II, Plasma, Journal Article, Humans, Aged, sphingolipids, Apolipoprotein A-I, Macrophages, Cholesterol, HDL, Original Articles, Middle Aged, Protective Factors, EMC COEUR-09-39-01, Lipocalins, Apolipoprotein M, Apolipoproteins, Cholesterol, Case-Control Studies, familial hypercholesterolaemia, sphingosine-phosphate, Lysophospholipids, cholesterol efflux, Apolipoprotein A-II, EMC COEUR-09
Adult, Male, Heterozygote, Coronary Disease, Apolipoproteins M, high-density lipoprotein, Hyperlipoproteinemia Type II, Plasma, Journal Article, Humans, Aged, sphingolipids, Apolipoprotein A-I, Macrophages, Cholesterol, HDL, Original Articles, Middle Aged, Protective Factors, EMC COEUR-09-39-01, Lipocalins, Apolipoprotein M, Apolipoproteins, Cholesterol, Case-Control Studies, familial hypercholesterolaemia, sphingosine-phosphate, Lysophospholipids, cholesterol efflux, Apolipoprotein A-II, EMC COEUR-09
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 36 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
